Aidigong Maternal & Child Health Files Director List with HKEX
Reuters
Dec 12
Aidigong Maternal & Child Health Files Director List with HKEX
Aidigong Maternal & Child Health Limited (Stock code: 286), incorporated in Bermuda, has filed an updated list of directors and their roles with the Hong Kong Stock Exchange. The Board comprises Executive Directors Mr. Huang Wenhua (Chairman and Chief Executive Officer), Mr. Lin Jiang, Mr. Li Runping, and Ms. Meng Lijia. Independent Non-Executive Directors include Mr. Wang Bin, Mr. Chu Pui Ki Dickson, and Mr. Ma Siu Kit. Mr. Wang Bin serves as Chairman of both the Nomination and Remuneration Committees and is a member of the Audit Committee. Mr. Chu Pui Ki Dickson is Chairman of the Audit Committee and serves as a member of the Nomination and Remuneration Committees. Ms. Meng Lijia is a member of the Nomination and Remuneration Committees, while Mr. Ma Siu Kit is a member of the Audit Committee.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aidigong Maternal & Child Health Limited published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251212-11954155), on December 12, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.